New Horizons in Chronic Lymphocytic Leukemia Treatment: 2023 Chronic Lymphocytic Leukemia 14 Mins Read5 Chronic Lymphocytic Leukemia (CLL) is a serious condition, and the current standard treatment involves a combination of Ibrutinib and Obinutuzumab…
IVO vs IO Phase 3 Trial of the Impact of Adding Venetoclax to Ibrutinib and Obinutuzumab in CLL Chronic Lymphocytic Leukemia 3 Mins Read3 Dr. Brian Hill, MD, PhD, from the Cleveland Clinic presented a study conducted through the Alliance and US cooperative groups,…
